Do glucagon, epinephrine, cortisol, and growth hormone raise blood glucose to protect the brain?

The body maintains a sophisticated, multi-layered defense system to ensure the brain—an organ that consumes approximately 20% of the body's glucose—receives a continuous supply of fuel. When blood glucose levels drop below physiological thresholds, a coordinated hormonal cascade is activated to restore glucose levels and prevent neuroglycopenia.

Physiological mechanisms of glucose recovery

The counterregulatory response is characterized by a hierarchical and sequential release of hormones that act on the liver, muscles, and fat tissue to mobilize energy:

• Immediate Defense (Glucagon and Epinephrine): As plasma glucose falls below approximately 68–80 mg/dL, the pancreas increases glucagon secretion. Glucagon is the primary driver of acute recovery, responsible for 50–70% of initial glucose production by triggering hepatic glycogenolysis (breaking down stored sugar) and gluconeogenesis (creating new sugar). Epinephrine (adrenaline) acts as a critical backup, rapidly stimulating glucose production and inhibiting peripheral glucose use when glucagon levels are insufficient.
• Delayed Defense (Growth Hormone and Cortisol): Growth hormone and cortisol provide sustained support during prolonged hypoglycemia. Growth hormone typically peaks 30–60 minutes after the initial drop, promoting fat breakdown (lipolysis) to provide alternative fuel. Cortisol is the slowest responder (appearing after 60 minutes), facilitating long-term glucose maintenance by promoting protein breakdown and further stimulating glucose production in the liver.

Protection of cerebral fuel supply

The brain acts as the command center for this response. Specialized glucose-sensing neurons in the ventromedial hypothalamus and hindbrain detect falling levels and trigger the systemic release of these counterregulatory hormones.

• Prioritizing the Brain: By increasing hepatic glucose output and simultaneously reducing glucose uptake in peripheral tissues (like muscle and fat), these hormones prioritize the systemic glucose pool for cerebral consumption.
• Maintaining the Gradient: Mechanistic studies show that during moderate hypoglycemia, the brain's metabolic rate of glucose remains stable. This stability is achieved because the hormonal response keeps blood glucose high enough to maintain the necessary concentration gradient for glucose to cross the blood-brain barrier via specialized GLUT1 transporters.

Bottom line

The claim that glucagon, epinephrine, cortisol, and growth hormone raise blood glucose to protect the brain's fuel supply is robustly supported by clinical evidence. This complex hormonal network ensures that blood glucose concentrations remain sufficient to cross the blood-brain barrier, preventing cognitive impairment and brain injury during metabolic challenges.